Clinical trial
A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management
NCT02187614 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management
- Lead sponsor
- Hamad Medical Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- March 31, 2015
- Enrollment
- 1,645 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.